# ZETA : Prospective Observational Study

> **NCT03730558** · — · COMPLETED · sponsor: **Recherche clinique** · enrollment: 120 (actual)

## Conditions studied

- Metastatic Colon Cancer

## Interventions

- **COMBINATION_PRODUCT:** aflibercept + FOLFIRI

## Key facts

- **NCT ID:** NCT03730558
- **Lead sponsor:** Recherche clinique
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-08
- **Primary completion:** 2021-11-08
- **Final completion:** 2021-11-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03730558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03730558, "ZETA : Prospective Observational Study". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT03730558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*